Physician

Bilal Ansari, M.D.

According to 2025 Medicare claims, Bilal Ansari, M.D. (NPI: 1386648749) practices medical oncology in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from St. Joseph, IN. This provider's primary affiliated billing organization is MICHIANA HEMATOLOGY-ONCOLOGY P C (NPI: 1619970183; TIN: 351686054) and primary practice location at 46545-1470. Ansari is affiliated with the CHA ACO, LLC (ACO ID: A2207), OSF Healthcare System (ACO ID: A3289), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,357 traditional Medicare patients, billed 156,704 HCPCS/CPT codes, and received $2,017,302 in Medicare payments. The top billing code was 74177 (Ct scan of abdomen and pelvis with contrast). Part D data shows 4,555 prescription claims across 751 beneficiaries totaling $11,728,488 in drug costs, led by Ibrance (Palbociclib). DME data shows 85 claims. Open Payments data shows 32 records totaling $2,170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,908,896 and ending at $2,017,302. Concurrently, Part D prescription costs have risen steadily, from $3,083,733 to $11,728,488. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $22,409 to $13,745.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,417	331,577	$3,908,896
2016	1,348	185,773	$2,365,157
2017	1,307	203,841	$3,171,350
2018	1,193	160,360	$1,895,999
2019	1,200	137,476	$2,087,796
2020	1,000	78,128	$1,217,091
2021	999	78,937	$1,466,073
2022	1,237	194,990	$4,313,195
2023	1,419	227,664	$3,490,775
2024	1,357	156,704	$2,017,302

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	3,024	$3,083,733
2016	587	3,636	$5,231,871
2017	558	3,116	$5,162,103
2018	594	3,398	$5,080,418
2019	631	3,601	$6,710,083
2020	625	3,803	$7,280,881
2021	517	2,896	$7,343,537
2022	524	2,410	$7,425,356
2023	690	3,836	$8,711,099
2024	751	4,555	$11,728,488

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	77	259	$26,325
2016	101	418	$52,764
2017	51	120	$10,674
2018	41	109	$10,082
2019	46	227	$23,885
2020	39	238	$21,756
2021	38	110	$11,074
2022	50	123	$13,084
2023	81	252	$44,024
2024	42	85	$9,800

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74177	Ct scan of abdomen and pelvis with contrast	159	215	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	892	2,230	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	614	892	$64
71260	Ct scan of chest with contrast	201	267	$46
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	218	28,320	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	85	2,495	$1,336,326
Revlimid	Lenalidomide	70	1,911	$1,215,635
Imbruvica	Ibrutinib	71	2,028	$1,062,455
Xtandi	Enzalutamide	69	2,070	$787,502
Pomalyst	Pomalidomide	35	971	$755,788

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	12	12	$4,521
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	30	39	$4,212
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	18	$784
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$282

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$2,170	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bilal Ansari, M.D.?

Tedicare shows public-source Medicare data for Bilal Ansari, M.D. (NPI 1386648749), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bilal Ansari, M.D. have ACO affiliation data?

Bilal Ansari, M.D. is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207), OSF Healthcare System (MSSP, ACO ID A3289), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Bilal Ansari, M.D.?

Bilal Ansari, M.D. is linked to MICHIANA HEMATOLOGY-ONCOLOGY P C (billing NPI 1619970183) in the available physician profile data.

Does Bilal Ansari, M.D. have Open Payments data?

Bilal Ansari, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.